Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
236,234,693
-
Total 13F shares
-
20,825,309
-
Share change
-
+2,623,919
-
Total reported value
-
$191,436,543
-
Put/Call ratio
-
23%
-
Price per share
-
$9.20
-
Number of holders
-
86
-
Value change
-
+$23,185,087
-
Number of buys
-
38
-
Number of sells
-
43
Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q1 2017
As of 31 Mar 2017 Akebia Therapeutics, Inc. - Common Stock (AKBA) had 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 20,825,309 shares of stock of the company.
Largest 10 holders included EAGLE ASSET MANAGEMENT INC, BlackRock Inc., Nantahala Capital Management, LLC, VANGUARD GROUP INC, Novo A/S, FIRST MANHATTAN CO, FMR LLC, MORGAN STANLEY, Marshall Wace North America L.P., and STATE STREET CORP.
This table shows 86 institutional shareholders of the security as of 31 Mar 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.